Clinical Trial Update: Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety of a triple combination of decitabine, arsenic trioxide, and ascorbic acid in patients with myelodysplastic syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Ascorbic acid (Vitamin C)
• Dacogen (decitabine)
• Trisenox (arsenic trioxide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Myelodysplastic Syndromes and Leukemia, Myeloid, Acute | Phase 1 | Status: COMPLETED